Original ResearchPublished 8 October 2026Longitudinal CT-derived muscle–fat–bone remodeling following androgen deprivation therapy initiation in prostate cancerManuela Montatore · Gianmichele Muscatella · Federica Masino · Eluisa Muscogiuri · Giuseppe GuglielmiFrontiers in Urologydoi 10.3389/fruro.2026.1985221
Systematic ReviewPublished 17 August 2026Use of androgen suppression therapy at salvage radiotherapy in recurrent prostate cancer: a systematic review with meta-analysisMaria Juliana Chaves Medina · Rodolfo Varela Ramírez · Wilfredo Donoso Donoso · Jaime Moreno-Chaparro · Javier Eslava-SchmalbachFrontiers in Urologydoi 10.3389/fruro.2026.1836469
Original ResearchPublished 7 August 2026Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapySheng-Chi Huang · Wan-Yu Cheng · Cheng-You Hou · Jheng-Yan Wu · Chih-Cheng Lai · Wen-Hsin TsengFrontiers in Urologydoi 10.3389/fruro.2026.1855180
